Drugs / The pentavalent rotavirus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05032391 | Feb → Sep 2019 | Rotavirus infection | Limited Liability Company Pharm Aid | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | The pentavalent rotavirus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05032391 ↗ |
| Modality | Vaccine | “The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried)” NCT05032391 ↗ |
| Route | Oral | “Three times orally in a volume of 2.5 ml (1 dose)” NCT05032391 ↗ |